Gibson, Dunn & Crutcher LLP advised Royalty Pharma in connection with its development funding.Royalty Pharma plc (Nasdaq: RPRX) and Teva Pharmaceuticals International GmbH, a subsidiary of…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Sonia Carcano
…
This content is for Standard 1 Year members only. LoginJoin Now